Skip to main content
. 2021 Jul 21;13(15):3651. doi: 10.3390/cancers13153651

Table 3.

A summary characterization of 3D in vitro models.

Type of 3D In Vitro Model Specific Features Biomedical Applications Reference(s)
Co-cultures
  • direct—different cells are cultured together

  • indirect—the cells are separated by a physical barrier

  • cells of different phenotypes do not grow together even when they are in direct contact

  • Cell–cell communication

  • Cell–microenvironment interactions

  • Cancer invasion

[89]
Spheroids
  • non-scaffold-based 3D model

  • round-shaped micro-sized cellular aggregates

  • can be generated either from 2D cell cultures (primary or immortalized cells) or tissue fragments

  • multilayer structure: (i) external layer—proliferative cells, (ii) middle layer—senescent cells, and (iii) core—necrotic cells

  • two types of tumor spheroids: homodymic, containing ex-clusively cancer cells, and heterodymic, containing tumor cells cul-tivated with other cell types

  • ECM consists of proteins produced by the cells during sphe-roid formation

  • Drug discovery

  • Disease modelling

  • Toxicity screening

  • High-throughput screening

[90,91,92]
Organoids
  • also known as “organ buds”

  • complex scaffold-free 3D models

  • stem cell organoids (derived from embryonic stem cells/induced pluripotent cells/primary stem cells)

  • tissue organoids (stromal cell-free culture)

  • ‘organ-in-a-dish’

  • in vivo-like complexity and architecture

  • Carcinogenesis studies

  • Anticancer drug screen-ing and discovery

  • Development of person-alized anticancer therapies

[12,37,90,92,93,94,95]
Scaffold-based models
  • 3D constructs providing a physical support (matrix) on which cells can proliferate, divide, and migrate

  • specifically designed to recapitulate the in vivo ECM

  • composed of natural (i.e., Matrigel, chitosan, hyaluronic acid, alginate) or synthetic (i.e., polyethylene glycol, polyvinyl alcohol) scaffolds

  • Drug screening and dis-covery

[92,96,97]
Bioprinted and 3D printed models
  • layer-by-layer deposed bioinks (i.e., cell pellets; decellularized ECM constituents) with 3D architecture

  • scaffold-free design—bioprinting on sacrificial materials (agarose; alginate), which are eventually discarded, or

  • scaffold-based design—bioprinting of hydrogel-encapsulated bioinks

  • Tissue engineering

  • Cancer pathology re-search

  • Anticancer drug discov-ery

[97,98]
Organ-on-a-chip
  • miniature microfluidic devices made of optically clear mate-rials (i.e., plastic, glass, polymers) containing microchannels popu-lated by living cells

  • extended viability of the cultured cells (weeks, months)

  • faithful simulation of the in vivo organ structure and func-tions

  • mimicking both the physiological and pathological features of the organ

  • Modeling of specific tumoral processes: growth, neovascularization and angiogenesis, progression from early to late stages, invasion, and metastasis

[92,99]